• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质聚集疾病与潜在药物制剂的探寻

Diseases of protein aggregation and the hunt for potential pharmacological agents.

作者信息

Wang Steven S-S, Wu Josephine W, Yamamoto Shuichi, Liu Hwai-Shen

机构信息

Department of Chemical Engineering, National Taiwan University, Taipei, Taiwan.

出版信息

Biotechnol J. 2008 Feb;3(2):165-92. doi: 10.1002/biot.200700065.

DOI:10.1002/biot.200700065
PMID:18034432
Abstract

Protein aggregation is a ubiquitous phenomenon significant to all aspects of science. Notably, the formation of protein aggregates is frequently encountered in biochemical research and biopharmaceutical industry. Formation of protein aggregates is generally regarded to be associated with partially folded intermediate species that are susceptible to self-association due to the exposure of hydrophobic core. Evidence supports the concept that the formation of aggregates in vitro is a generic property of proteins. In human etiology, more than 20 different devastating human diseases have been reported to be associated with protein aggregation. Although protein aggregation diseases have been the center of intense research, much remains to be learned regarding the underlying molecular mechanisms. In this review, the general background information on protein aggregation is first provided. Next, we summarize the properties, characteristics and causes of protein aggregates. Finally, from the perspectives of epidemiology, pathogenesis, existing mechanisms, relevant hypotheses, and current as well as potential therapeutic approaches, two examples of protein aggregation diseases, Alzheimer's disease and cataract, are briefly discussed. Importantly, while a variety of molecules have been suggested, the effective therapeutic drugs for curing the diseases involving protein aggregation have yet to be identified. We believe that a better understanding of the mechanisms of protein aggregation process and an extensive investigation into the drug penetration, efficacy, and side effects will certainly aid in developing the successful pharmacological agents for these diseases.

摘要

蛋白质聚集是一种普遍存在的现象,对科学的各个方面都具有重要意义。值得注意的是,在生化研究和生物制药行业中经常会遇到蛋白质聚集体的形成。蛋白质聚集体的形成通常被认为与部分折叠的中间物种有关,这些中间物种由于疏水核心的暴露而易于自我缔合。有证据支持这样的观点,即体外聚集体的形成是蛋白质的一种普遍特性。在人类病因学中,据报道有20多种不同的毁灭性人类疾病与蛋白质聚集有关。尽管蛋白质聚集疾病一直是深入研究的核心,但关于其潜在的分子机制仍有许多有待了解。在这篇综述中,首先提供了关于蛋白质聚集的一般背景信息。接下来,我们总结了蛋白质聚集体的性质、特征和成因。最后,从流行病学、发病机制、现有机制、相关假说以及当前和潜在的治疗方法等角度,简要讨论了两种蛋白质聚集疾病的例子,即阿尔茨海默病和白内障。重要的是,虽然已经提出了多种分子,但尚未确定治疗涉及蛋白质聚集疾病的有效治疗药物。我们相信,更好地理解蛋白质聚集过程的机制,并广泛研究药物的渗透性、疗效和副作用,肯定有助于开发出针对这些疾病的成功药物。

相似文献

1
Diseases of protein aggregation and the hunt for potential pharmacological agents.蛋白质聚集疾病与潜在药物制剂的探寻
Biotechnol J. 2008 Feb;3(2):165-92. doi: 10.1002/biot.200700065.
2
Novel therapeutic strategies for the treatment of protein-misfolding diseases.治疗蛋白质错误折叠疾病的新型治疗策略。
Expert Rev Mol Med. 2007 Jun 28;9(17):1-34. doi: 10.1017/S1462399407000385.
3
Unraveling the mysteries of protein folding and misfolding.揭开蛋白质折叠与错误折叠的奥秘。
IUBMB Life. 2008 Dec;60(12):769-74. doi: 10.1002/iub.117.
4
How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.细胞如何处理异常蛋白质。蛋白质聚集疾病中的致病机制。
Pathobiology. 2007;74(3):145-58. doi: 10.1159/000103374.
5
Therapeutic approaches to protein-misfolding diseases.蛋白质错误折叠疾病的治疗方法。
Nature. 2003 Dec 18;426(6968):905-9. doi: 10.1038/nature02265.
6
Mechanical stress and formation of protein aggregates in neurodegenerative disorders.神经退行性疾病中的机械应力与蛋白质聚集体的形成
Med Hypotheses. 2008;70(5):1034-7. doi: 10.1016/j.mehy.2007.06.043. Epub 2007 Oct 29.
7
Protein misfolding and aggregation.蛋白质错误折叠与聚集。
Biotechnol Prog. 2007 May-Jun;23(3):548-52. doi: 10.1021/bp060374h. Epub 2007 Apr 11.
8
[Protein-condensation diseases--molecular basis of cataract formation].
Klin Monbl Augenheilkd. 2000 Feb;216(2):75-8. doi: 10.1055/s-2000-10521.
9
The structural basis of protein folding and its links with human disease.蛋白质折叠的结构基础及其与人类疾病的联系。
Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):133-45. doi: 10.1098/rstb.2000.0758.
10
Topology-based potentials and the study of the competition between protein folding and aggregation.基于拓扑学的势能与蛋白质折叠和聚集之间竞争的研究。
J Chem Phys. 2009 Mar 21;130(11):115101. doi: 10.1063/1.3089708.

引用本文的文献

1
yGPS-P: A Yeast-Based Peptidome Screen for Studying Quality Control-Associated Proteolysis.酵母源多肽组筛选技术用于研究与质量控制相关的蛋白水解
Biomolecules. 2023 Jun 14;13(6):987. doi: 10.3390/biom13060987.
2
Application of Amyloid-Based Hybrid Membranes in Drug Delivery.基于淀粉样蛋白的混合膜在药物递送中的应用。
Polymers (Basel). 2023 Mar 14;15(6):1444. doi: 10.3390/polym15061444.
3
Precipitation-free high-affinity multivalent binding by inline lectin ligands.通过串联凝集素配体实现无沉淀的高亲和力多价结合。
Chem Sci. 2020 Apr 27;11(20):5227-5237. doi: 10.1039/d0sc01744b.
4
Discovery and characterization of a photo-oxidative histidine-histidine cross-link in IgG1 antibody utilizing ¹⁸O-labeling and mass spectrometry.利用¹⁸O标记和质谱法发现并表征IgG1抗体中的光氧化组氨酸-组氨酸交联
Anal Chem. 2014 May 20;86(10):4940-8. doi: 10.1021/ac500334k. Epub 2014 May 2.
5
Cellular maintenance of nuclear protein homeostasis.细胞内核蛋白稳态的维持。
Cell Mol Life Sci. 2014 May;71(10):1865-79. doi: 10.1007/s00018-013-1530-y. Epub 2013 Dec 5.
6
Substrate recognition in nuclear protein quality control degradation is governed by exposed hydrophobicity that correlates with aggregation and insolubility.核蛋白质量控制降解中的底物识别受暴露的疏水性控制,疏水性与聚集和不溶性相关。
J Biol Chem. 2013 Mar 1;288(9):6130-9. doi: 10.1074/jbc.M112.406710. Epub 2013 Jan 18.
7
Bovine serum albumin oligomers in the E- and B-forms at low protein concentration and ionic strength.低蛋白浓度和离子强度下的 E 型和 B 型牛血清白蛋白寡聚物。
Int J Biol Macromol. 2013 Feb;53:42-53. doi: 10.1016/j.ijbiomac.2012.10.030. Epub 2012 Nov 10.
8
Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.哺乳动物细胞表达的重组蛋白治疗药物无血浆制造的新趋势。
Biotechnol J. 2009 Feb;4(2):186-201. doi: 10.1002/biot.200800241.